SCNX News

Latest breaking news and updates for SCNX stock.

Scienture Holdings, Inc. Announces Pricing of $3.9 Million Registered Direct Offering of Common Stock

Commack, NY, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Scienture Holdings, Inc. (Nasdaq: SCNX) (“Scienture” or the “Company”), a holding company for existing and planned pharmaceutical operating companie...

How does this direct offering compare to other financing options (e.g., secondary offering, private placement) in terms of cost and speed? What is the role and compensation of the placement agent, and how might that affect net proceeds? Are there any regulatory or filing deadlines that could affect the timing or execution of the offering?

Financing

9 days ago

SCIENTURE announces the shipment of launch quantities of Arbli™ (losartan potassium Oral Suspension) to its 3PL/Distribution Center and receipt of first wholesaler order, marking major commercialization milestones.

COMMACK, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced ...

How might this milestone influence analyst sentiment and the stock's valuation multiples? Will the launch of Arbli™ have any impact on Scienture's cash flow or capital allocation plans? What competitive advantages does Arbli™ have over existing losartan products in the market?

Product launch

10 days ago